Filatex India FY26 PAT Jumps 37% to Rs 184 Crore; Rs 690 Cr Capex Announced

TEXTILE
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
Filatex India FY26 PAT Jumps 37% to Rs 184 Crore; Rs 690 Cr Capex Announced

Filatex India reported a 36.66% rise in FY26 net profit despite a slight dip in revenue. The company announced a major Rs 690 crore capital expenditure program focused on chemical recycling and capacity expansion, signaling a strategic shift toward sustainability and growth.

Filatex India Posts Strong Profit Growth Amidst Major Capex Rollout

Filatex India reported a FY26 net profit of Rs 183.90 crore, up 36.66% from Rs 134.57 crore in the previous year. Operating revenue saw a marginal decline to Rs 4,160.52 crore, compared to Rs 4,252.15 crore in FY25.

Reader Takeaway: Strong operational margins driven by efficiency, though future growth hinges on timely execution of large capital projects.

What just happened

Filatex India has concluded its fiscal year with a significant improvement in profitability, attributed to a better product mix and rigorous cost control. The company’s EBITDA margin expanded to 8.33% from 6.06% in FY25. Parallel to these results, the Board has approved a Rs 690 crore capex plan, marking a significant phase of investment in future capabilities.

Why this matters

The company is aggressively moving into circular economy initiatives. The centerpiece is a Rs 300 crore 'Ecosis' chemical recycling plant in Dahej, capable of producing 27,000 TPA of recycled textile material, expected to be ready by October 2026. This transition is essential for the company to align with global shifts toward sustainable textile manufacturing.

The backstory

Over the last few years, the company has successfully deleveraged its balance sheet. Chairman and Managing Director Madhu Sudhan Bhageria noted that the debt-to-equity ratio has dropped from 0.33 in FY22 to 0.08 in FY26, creating the necessary financial runway to fund these large-scale expansions through internal accruals and existing strength.

Risks to watch

External volatility, particularly geopolitical tensions in the Middle East affecting raw material costs like paraxylene and MEG, remains a concern. Furthermore, the company faces execution risk; any delays in the commissioning of the new chemical recycling or expansion projects could impact projected returns.

What to track next

Investors should monitor the October 2026 commissioning target for the Ecosis facility. Additionally, tracking the stabilization of new capacity and the impact of fluctuating input costs on the firm’s operating margins will be key for the next fiscal.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.